Amended Statement of Ownership (sc 13g/a)
05 Aprile 2017 - 8:42PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G/A
(Rule
13d-102)
Information to be Included in Statements filed Pursuant to Rule
13d-1(b),
(c) and (d) and Amendments Thereto Filed Pursuant to Rule
13d-2
(Amendment No. 2)*
BIOPTIX, INC.
(Name of
Issuer)
Common Stock
(Title of Class of Securities)
92262A206
(CUSIP NUMBER)
March 31, 2017
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
☐ Rule
13d-1(b)
☒
Rule
13d-1(c)
☐ Rule
13d-1(d)
*
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
|
The information required on the remainder of this cover page
shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however,
see
the
Notes
).
|
|
|
Cusip No. 92262A206
|
|
Page
2
of 8 Pages
|
SCHEDULE 13G
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons:
Remeditex Ventures LLC
|
2.
|
|
Check the appropriate box if a member
of a group
(a) ☐ (b) ☒ (joint filers)
|
3.
|
|
SEC Use Only.
|
4.
|
|
Citizenship or Place of
Organization
Texas
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
5.
|
|
Sole Voting Power
0
|
|
6.
|
|
Shared Voting Power
0
|
|
7.
|
|
Sole Dispositive Power
0
|
|
8.
|
|
Shared Dispositive Power
0
|
9.
|
|
Aggregate amount beneficially owned by each reporting person
0
|
10.
|
|
Check box if the aggregate amount in
row 9 excludes certain shares
☐
|
11.
|
|
Percent of class represented by amount
in row 9
0%
|
12.
|
|
Type of Reporting Person
OO
|
|
|
|
Cusip No. 92262A206
|
|
Page
3
of 8 Pages
|
SCHEDULE 13G
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons:
Malachite Trust
|
2.
|
|
Check the appropriate box if a member
of a group
(a) ☐ (b) ☒ (joint filers)
|
3.
|
|
SEC Use Only.
|
4.
|
|
Citizenship or Place of
Organization
Texas
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
5.
|
|
Sole Voting Power
0
|
|
6.
|
|
Shared Voting Power
0
|
|
7.
|
|
Sole Dispositive Power
0
|
|
8.
|
|
Shared Dispositive Power
0
|
9.
|
|
Aggregate amount beneficially owned by each reporting person
0
|
10.
|
|
Check box if the aggregate amount in
row 9 excludes certain shares
☐
|
11.
|
|
Percent of class represented by amount
in row 9
0%
|
12.
|
|
Type of Reporting Person
OO
|
|
|
|
Cusip No. 92262A206
|
|
Page
4
of 8 Pages
|
SCHEDULE 13G
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons:
Lyda Hill
|
2.
|
|
Check the appropriate box if a member
of a group
(a) ☐ (b) ☒ (joint filers)
|
3.
|
|
SEC Use Only.
|
4.
|
|
Citizenship or Place of
Organization
United States
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
5.
|
|
Sole Voting Power
0
|
|
6.
|
|
Shared Voting Power
0
|
|
7.
|
|
Sole Dispositive Power
0
|
|
8.
|
|
Shared Dispositive Power
0
|
9.
|
|
Aggregate amount beneficially owned by each reporting person
0
|
10.
|
|
Check box if the aggregate amount in
row 9 excludes certain shares
☐
|
11.
|
|
Percent of class represented by amount
in row 9
0%
|
12.
|
|
Type of Reporting Person
IN
|
|
|
|
Cusip No. 92262A206
|
|
Page
5
of 8 Pages
|
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
Item 1(a).
|
Name of Issuer
:
|
Bioptix, Inc.
Item 1(b).
|
Address of Issuers Principal Executive Offices
:
|
1775 38
th
Street, Boulder, CO 80301
Item 2(a).
|
Name of Person Filing
:
|
This statement is filed on behalf of (1) Remeditex
Ventures LLC, (2) Malachite Trust and (3) Lyda Hill.
Item 2(b).
|
Address of Principal Business Office or, if none, Residence
:
|
2727 N. Harwood St.
Suite 200
Dallas, Texas 75201
Remeditex Ventures LLC and Malachite Trust Texas
Lyda Hill - United States of America.
Item 2(d).
|
Title of Class
of Securities
:
|
Common Stock, no par value (the
Common Stock)
Item 2(e).
|
CUSIP Number
.
|
The Issuers CUSIP Number is 92262A206
Item 3.
|
If this Statement is filed pursuant to Rule
13d-1(b),
or
13d-2(b),
or (c), check whether the person filing is a
:
|
Not Applicable.
|
|
|
|
|
(a)
|
|
Amount beneficially owned:
|
|
|
|
|
|
|
|
Remeditex Ventures LLC
|
|
0
|
|
|
Malachite Trust
|
|
0
|
|
|
Lyda Hill
|
|
0
|
|
|
|
Cusip No. 92262A206
|
|
Page
6
of 8 Pages
|
|
|
|
|
|
|
|
|
(b)
|
|
Percent of Class:
|
|
|
|
|
|
|
|
Remeditex Ventures LLC
|
|
0%
|
|
|
Malachite Trust
|
|
0%
|
|
|
Lyda Hill
|
|
0%
|
|
|
|
|
|
|
|
|
|
(c)
|
|
Number of shares as to which such person has:
|
|
|
|
|
|
(i)
|
|
Sole power to vote or to direct the vote:
|
|
|
|
|
|
|
|
|
Remeditex Ventures LLC
|
|
0
|
|
|
|
|
Malachite Trust
|
|
0
|
|
|
|
|
Lyda Hill
|
|
0
|
|
|
|
|
|
(ii)
|
|
Shared power to vote or to direct the vote:
|
|
|
|
|
|
|
|
|
Remeditex Ventures LLC
|
|
0
|
|
|
|
|
Malachite Trust
|
|
0
|
|
|
|
|
Lyda Hill
|
|
0
|
|
|
|
|
|
(iii)
|
|
Sole power to dispose or to direct the disposition of:
|
|
|
|
|
|
|
|
|
Remeditex Ventures LLC
|
|
0
|
|
|
|
|
Malachite Trust
|
|
0
|
|
|
|
|
Lyda Hill
|
|
0
|
|
|
|
|
|
(iv)
|
|
Shared power to dispose or to direct the disposition of:
|
|
|
|
|
|
|
|
|
Remeditex Ventures LLC
|
|
0
|
|
|
|
|
Malachite Trust
|
|
0
|
|
|
|
|
Lyda Hill
|
|
0
|
Item 5.
|
Ownership of Five Percent or Less of a Class
.
|
This Schedule 13G/A is being filed to
report that the reporting person has as of March 31, 2017, ceased to be the beneficial owner of more than 5% of the Common Stock of Bioptix, Inc.
☒
.
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
.
|
Not Applicable.
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
.
|
Not Applicable.
|
|
|
Cusip No. 92262A206
|
|
Page
7
of 8 Pages
|
Item 8.
|
Identification and Classification of Members of the Group
.
|
Not Applicable.
Item 9.
|
Notice of Dissolution of Group
.
|
Not Applicable.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as
a participant in any transaction having that purpose or effect.
Exhibits:
Exhibit 1*
|
Joint Filing Agreement, dated September 19, 2016, by and among Remeditex Ventures LLC, Malachite Trust and Lyda Hill.
|
*
|
Previously filed as an Exhibit to the Schedule 13G filed on September 19, 2016.
|
|
|
|
Cusip No. 92262A206
|
|
Page
8
of 8 Pages
|
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: April 5, 2017
|
|
|
Remeditex Ventures LLC
|
|
|
By:
|
|
/s/ Brett Ringle
|
|
|
Brett Ringle, President
|
|
Malachite Trust
|
|
|
By:
|
|
/s/ Lyda Hill
|
|
|
Lyda Hill, Trustee
|
|
/s/ Lyda Hill
|
|
|
Lyda Hill
|
Grafico Azioni Bioptix, Inc. (NASDAQ:BIOP)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Bioptix, Inc. (NASDAQ:BIOP)
Storico
Da Lug 2023 a Lug 2024